PTLF (Petlife Pharmaceuticals) Total Assets: $0.01 Mil (As of Feb. 2018)


What is Petlife Pharmaceuticals Total Assets?

Petlife Pharmaceuticals PTLF Total Assets is $0.01 Mil as of Feb. 2018.

Petlife Pharmaceuticals's Total Assets for the quarter that ended in Feb. 2018 was $0.01 Mil.

Total Assets is connected with ROA %. Petlife Pharmaceuticals's annualized ROA % for the quarter that ended in Feb. 2018 was -5,175.76%. Total Assets is also linked to Revenue through Asset Turnover. Petlife Pharmaceuticals's Asset Turnover for the quarter that ended in Feb. 2018 was 0.00.

Petlife Pharmaceuticals  (OTCPK:PTLF) Total Assets Explanation

Total Assets is connected with ROA %.

Petlife Pharmaceuticals's annualized ROA % for the quarter that ended in Feb. 2018 is

ROA %=Net Income (Q: Feb. 2018 )/( (Total Assets (Q: Nov. 2017 )+Total Assets (Q: Feb. 2018 ))/ count )
=-1.708/( (0.058+0.008)/ 2 )
=-1.708/0.033
=-5,175.76 %

Note: The Net Income data used here is four times the quarterly (Feb. 2018) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Petlife Pharmaceuticals's Asset Turnover for the quarter that ended in Feb. 2018 is

Asset Turnover
=Revenue (Q: Feb. 2018 )/( (Total Assets (Q: Nov. 2017 )+Total Assets (Q: Feb. 2018 ))/ count )
=0/( (0.058+0.008)/ 2 )
=0/0.033
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Petlife Pharmaceuticals Total Assets Related Terms

Petlife Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Total Assets Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.02 0.01 0.00 0.06

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.27 0.06 0.06 0.01

Petlife Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Petlife Pharmaceuticals's Total Assets for the fiscal year that ended in Aug. 2017 is calculated as

Total Assets=Total Equity (A: Aug. 2017 )+Total Liabilities (A: Aug. 2017 )
=-1.381+1.436
=0.05

Petlife Pharmaceuticals's Total Assets for the quarter that ended in Feb. 2018 is calculated as

Total Assets=Total Equity (Q: Feb. 2018 )+Total Liabilities (Q: Feb. 2018 )
=-1.973+1.981
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.01 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Total Assets of $0.01 Mil as of Feb. 2018. The total amount of assets as recorded on a company's balance sheet. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Total Assets too high?
Petlife Pharmaceuticals' current Total Assets is $0.01 Mil.
How does Petlife Pharmaceuticals' Total Assets compare to PCYN and YBAO?
Petlife Pharmaceuticals' Total Assets of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Total Assets is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Total Assets of $0.01 Mil. The current Total Assets is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Total Assets is $0.01 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.